KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Debt Ratio (2018 - 2025)

Historic Debt Ratio for Esperion Therapeutics (ESPR) over the last 3 years, with Q3 2025 value amounting to 0.42.

  • Esperion Therapeutics' Debt Ratio changed N/A to 0.42 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.42, marking a year-over-year change of. This contributed to the annual value of 0.41 for FY2024, which is N/A changed from last year.
  • Per Esperion Therapeutics' latest filing, its Debt Ratio stood at 0.42 for Q3 2025.
  • Esperion Therapeutics' Debt Ratio's 5-year high stood at 0.44 during Q1 2025, with a 5-year trough of 0.41 in Q4 2024.